What the AMC tests in antenatal care
Antenatal care questions are usually set in general practice or a hospital antenatal clinic. The patient is well or has a mild symptom, and the question asks what to offer, test, prescribe or explain. These are not dramatic stems, which is why candidates lose marks on them: the answer depends on knowing the routine schedule exactly and spotting the one finding that changes it.
Expect three broad types. First, screening and routine care: what to test at booking, when to do the dating and morphology scans, which vaccines to give and when to test for gestational diabetes. Second, medical problems in pregnancy: thyroid disease, epilepsy, venous thromboembolism, anaemia, cholestasis and nausea that has become hyperemesis. Third, specific risks to the fetus: infection exposure, red cell antibodies, growth restriction and twins.
Lead-ins are mostly 'most appropriate next step', 'most appropriate investigation' or 'most appropriate advice'. The examiners like options that are all reasonable things to do at some point in pregnancy. Your job is to pick the one that fits this gestation and this result. Write the gestational age down in your head before you read the options.
- Setting: GP shared care, midwife clinic, rural practice or antenatal day assessment
- Common lead-ins: next step, best investigation, correct advice, safest medication
- Core skill: matching the action to the gestation and the result in front of you
- Overlap: pre-eclampsia, early pregnancy and labour have their own pages on this site
Booking visit, routine tests and aneuploidy screening
The first visit should happen in the first trimester, ideally before 10 weeks. It sets up everything else: dating, risk assessment, blood tests, lifestyle advice and the plan for who provides care. Many AMC questions ask which test is part of routine booking and which is only for women with risk factors. Learn the two lists separately.
Aneuploidy screening is offered to every woman, whatever her age. The choice is between combined first-trimester screening (nuchal translucency plus maternal serum markers, done roughly 11 to 13+6 weeks) and cell-free DNA testing from about 10 weeks. Both are screening tests. A high-chance result needs a diagnostic test, chorionic villus sampling or amniocentesis, before any decision about the pregnancy. Low-chance cfDNA results with a large nuchal translucency still need further assessment, because cfDNA does not detect structural anomalies.
- Offer to all at booking: full blood count, blood group and antibody screen, rubella immunity, syphilis, hepatitis B, hepatitis C, HIV, midstream urine for asymptomatic bacteriuria
- Offer by risk or context: chlamydia testing in younger women, thyroid function if risk factors, vitamin D if at risk, haemoglobinopathy screening by ancestry or red cell indices, varicella immunity if history unclear
- Syphilis: test at booking; in outbreak areas repeat at 28 and 36 weeks, at birth and 6 weeks after birth (check state advice)
- Asymptomatic bacteriuria: treat it, because it raises the risk of pyelonephritis and preterm birth
- Dating scan if dates are uncertain; morphology scan at about 18–20 weeks
- Folic acid 0.4–0.5 mg daily before conception and through the first trimester; 5 mg for higher-risk women (previous neural tube defect, antiepileptic drugs, diabetes, obesity)
- Iodine 150 micrograms daily for pregnant and breastfeeding women unless thyroid disease makes it unsuitable
Vaccines and infections in pregnancy
Vaccine questions are easy marks if you know the Australian Immunisation Handbook schedule. Inactivated vaccines are safe in pregnancy. Live vaccines (MMR, varicella) are not given in pregnancy but are given postpartum if the woman is non-immune, including while breastfeeding.
Infection questions usually describe an exposure: a child with a rash at home, a cat, soft cheese, a job in child care. Ask three things. Is she immune? How far along is she? Is there a time-limited treatment? Varicella exposure in a non-immune woman is the classic time-critical case, because zoster immunoglobulin must be given early after contact. Parvovirus B19 can cause fetal anaemia and hydrops, so the follow-up is serial ultrasound with middle cerebral artery Doppler, not reassurance. Primary CMV is the commonest congenital infection, but Australia does not routinely screen for it; prevention advice on hand hygiene and avoiding young children's saliva is the tested point.
- Pertussis (dTpa): every pregnancy, ideally between 20 and 32 weeks, can be given up to delivery
- Influenza: any trimester, as soon as the seasonal vaccine is available
- RSV: a maternal RSV vaccine is funded in Australia in the third trimester to protect the newborn; infant monoclonal antibody is the alternative if the mother was not vaccinated
- Non-immune to rubella: avoid exposure, vaccinate with MMR after birth
- Varicella contact, non-immune: check serology urgently and give zoster immunoglobulin within the Handbook window; consider antiviral treatment if chickenpox develops
- Listeria: avoid high-risk foods; fever in pregnancy with flu-like illness needs blood cultures and amoxicillin cover
- Toxoplasmosis: avoid undercooked meat and cat litter; no routine screening in Australia
- Group B streptococcus: Australian units use either universal swab screening at 35–37 weeks or a risk-factor approach; know both
Gestational diabetes and Rh(D) isoimmunisation
Gestational diabetes is one of the most tested antenatal topics. Australia follows the Australian Diabetes in Pregnancy Society (ADIPS). The 2025 ADIPS consensus raised the oral glucose tolerance test thresholds and changed early testing. Under it, a 75 g OGTT is offered to all women at 24 to 28 weeks unless diabetes is already diagnosed. GDM is diagnosed if any one value is met: fasting 5.3 mmol/L or more, 1-hour 10.6 mmol/L or more, or 2-hour 9.0 mmol/L or more. Women with risk factors have an HbA1c early in pregnancy, and an early OGTT is kept for those with previous GDM or a borderline HbA1c. Older question banks and textbooks still quote the 2014 thresholds, so read the stem's numbers carefully and expect the exam to move to the new ones over time.
Overt diabetes in pregnancy is different from GDM. A fasting glucose of 7.0 mmol/L or more, a 2-hour value of 11.1 mmol/L or more, or an HbA1c of 6.5% or more at any gestation means diabetes that probably predates the pregnancy. That woman needs closer care, early fetal anomaly assessment and treatment from diagnosis.
For Rh(D), the logic is simple: an RhD-negative woman without anti-D antibodies is given prophylactic anti-D so she does not become sensitised. Routine antenatal doses are given in the third trimester, at about 28 and 34 weeks, plus a dose after any sensitising event and after birth if the baby is RhD positive. A Kleihauer test after birth or a large sensitising event measures how much fetal blood has entered the maternal circulation, which decides whether extra anti-D is needed. The 2024 national guideline supports fetal RHD genotyping from maternal blood so anti-D can be targeted to women carrying an RhD-positive baby; access and funding are still settling, so the exam is more likely to test the principle.
- GDM first-line management: diet and activity advice with a dietitian, self-monitoring of capillary glucose
- Add medication if targets are not met: insulin is standard; metformin is used in many units
- GDM follow-up: OGTT about 6–12 weeks after birth and long-term diabetes screening, because type 2 diabetes risk stays high
- Sensitising events: miscarriage or termination, ectopic pregnancy, antepartum bleeding, abdominal trauma, external cephalic version, invasive procedures
- If anti-D antibodies are already present (alloimmunised): prophylaxis is pointless; refer to fetal medicine for titres and middle cerebral artery Doppler
- Give anti-D within 72 hours of the event; if missed, some benefit remains up to about 10 days
Nausea, medical disorders and cholestasis
Nausea and vomiting peak in the first trimester. Hyperemesis gravidarum means weight loss, dehydration, ketosis or electrolyte upset. Rule out other causes: urinary infection, molar pregnancy, twins, thyroid disease. Treatment steps up from small frequent meals and ginger, to pyridoxine with doxylamine, to antiemetics such as metoclopramide or ondansetron, to admission for IV fluids. Give thiamine before or with dextrose in prolonged vomiting to prevent Wernicke encephalopathy, and give VTE prophylaxis to admitted women.
Medical disorders follow a pattern in the exam. The question gives a woman on a regular drug who is now pregnant or planning pregnancy and asks you to change, continue or monitor it. Know the drugs that must stop (valproate where possible, warfarin in most cases, ACE inhibitors, statins, isotretinoin, methotrexate) and the drugs that are continued with adjustment (levothyroxine, lamotrigine, insulin, low molecular weight heparin).
Intrahepatic cholestasis of pregnancy presents in the third trimester with itch of the palms and soles, no rash, and raised serum bile acids. It resolves after birth. The risk is stillbirth, which rises with higher bile acid levels. Ursodeoxycholic acid relieves itch. Timing of birth depends on bile acid level. Acute fatty liver of pregnancy and HELLP syndrome are the dangerous differentials: think of them if the woman is unwell, vomiting, hypoglycaemic or has low platelets.
- Hypothyroidism: increase levothyroxine as soon as pregnancy is confirmed (often two extra doses per week), check TSH every 4–6 weeks
- Hyperthyroidism: propylthiouracil is preferred in the first trimester; carbimazole is preferred later because of propylthiouracil liver toxicity
- Epilepsy: continue the effective drug; switch from valproate before conception if possible; folic acid 5 mg; lamotrigine levels fall in pregnancy
- VTE: treat with therapeutic low molecular weight heparin; warfarin is avoided (embryopathy) except in some mechanical heart valves under specialist care
- Iron deficiency anaemia: oral iron first; IV iron if oral fails or late in the third trimester
- Australian drug categories A, B1–B3, C, D and X come from the TGA, not the old US FDA letters
Multiple pregnancy and fetal growth restriction
For twins, chorionicity matters more than anything else, and it is best determined by ultrasound in the first trimester (lambda sign for dichorionic, T sign for monochorionic). Monochorionic twins share a placenta and can develop twin-to-twin transfusion syndrome, so they have ultrasound every two weeks from about 16 weeks. Twin pregnancies also carry more anaemia, pre-eclampsia, GDM and preterm birth, so the right answer often involves aspirin, iron and earlier scans.
A small-for-gestational-age fetus has an estimated fetal weight or abdominal circumference below the 10th centile. Fetal growth restriction means the fetus is not reaching its growth potential, often from placental insufficiency. Umbilical artery Doppler is the key test: absent or reversed end-diastolic flow is serious and moves the decision towards delivery. In the exam, a fundal height that is small for dates should lead to an ultrasound for growth and Doppler, not to reassurance or a repeat measurement in four weeks.
- Fundal height in centimetres roughly equals gestation in weeks from about 24 weeks; a difference of 3 cm or more needs an ultrasound
- Risk factors for growth restriction: smoking, pre-eclampsia, previous small baby, chronic hypertension, renal disease
- Reduced fetal movements: same-day CTG and assessment, not advice to wait
- Monoamniotic twins need specialist care and earlier planned birth
Australian practice that differs from the UK and US
Several antenatal points differ between countries, and the AMC expects the Australian answer. Candidates who trained in the UK or South Asia often answer from NICE or local hospital rules. Look at the list below and check each against what you learned.
- GDM: ADIPS criteria (2025 thresholds: fasting 5.3, 1-hour 10.6, 2-hour 9.0 mmol/L), not NICE (fasting 5.6, 2-hour 7.8) or two-step US screening
- Universal OGTT at 24–28 weeks rather than testing only women with risk factors
- Syphilis: repeat testing at 28 and 36 weeks, birth and 6 weeks postpartum in outbreak areas, because of rising congenital syphilis
- Maternal RSV vaccine is funded in the third trimester
- Drug safety uses TGA pregnancy categories
- Shared care between GP and hospital is common; know the referral triggers
- Aboriginal and Torres Strait Islander women: culturally safe care, Aboriginal health workers and higher-risk screening (for example, earlier diabetes testing)
How to read antenatal stems
Start with gestation. The same symptom means different things at 8, 22 and 36 weeks. Then look for the one abnormal result or exposure. Most antenatal stems contain a lot of normal information and a single detail that decides the answer: an RhD-negative group, a borderline glucose, a non-immune serology, a small fundal height.
Then ask whether the question wants a test, a treatment or a referral. If the result is a screening result, the next step is usually a confirmatory test, not treatment. If the woman is unwell (fever, pain, bleeding, high blood pressure, reduced movements), the answer moves from routine care to same-day assessment. The AMC often puts a sensible routine option next to an urgent one; when there is a red flag, choose the urgent one.
- Red flags: headache or visual change after 20 weeks, reduced fetal movements, bleeding, fever, severe itch with jaundice, chest pain or breathlessness
- Screening positive: confirm with a diagnostic test before acting
- Drug questions: pick the option that keeps the mother well, not the one that avoids all drugs
- If two options are both correct, choose the one that must happen first
| Gestation | What happens | Why the exam cares |
|---|---|---|
| Before 10 weeks | Booking visit, booking bloods, folic acid and iodine, risk assessment | Defines which tests are routine and which are targeted |
| 10–14 weeks | Dating scan if needed, cfDNA or combined first-trimester screening offered, early HbA1c if risk factors | Screening versus diagnostic test logic |
| 16 weeks onwards | Two-weekly scans for monochorionic twins | TTTS surveillance |
| 18–20 weeks | Morphology ultrasound, placental site | Low placenta needs a repeat scan later |
| 20–32 weeks | dTpa vaccine; influenza vaccine any time | Vaccine timing questions |
| 24–28 weeks | 75 g OGTT for all without known diabetes | ADIPS thresholds |
| 28 weeks | FBC, antibody screen, first routine anti-D if RhD negative; repeat syphilis in outbreak areas | Anaemia and isoimmunisation |
| 28–36 weeks | Maternal RSV vaccine window | Newly funded Australian program |
| 34–37 weeks | Second routine anti-D; GBS swab where universal screening is used; check presentation | ECV discussion if breech |
| 41 weeks | Discuss induction of labour | Post-term stillbirth risk |
Worked examples in AMC style
Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for antenatal care.
Example 1
A 29-year-old woman, G2P1, attends her GP at 26 weeks' gestation for results of a 75 g oral glucose tolerance test. Her fasting glucose is 5.5 mmol/L, 1-hour 9.8 mmol/L and 2-hour 8.1 mmol/L. Her first pregnancy was uncomplicated. Her BMI is 27 kg/m2 and blood pressure is 112/70 mmHg.
What is the most appropriate next step?
-
Repeating a diagnostic test that is already positive delays treatment and is not recommended.
-
Medication is added only if targets are not met after diet and monitoring; a growth scan is not the first step.
-
A fasting value of 5.5 mmol/L meets the ADIPS threshold (5.3 or more). One value is enough to diagnose GDM. First-line care is dietitian input and self-monitoring.
-
One abnormal value is enough for the diagnosis, so reassurance is wrong.
-
HbA1c is not used to confirm GDM at this gestation and is less sensitive than the OGTT.
Show answer and reasoning
Answer: C. Diagnose GDM; refer for diet and glucose checks
- A. Repeating a diagnostic test that is already positive delays treatment and is not recommended.
- B. Medication is added only if targets are not met after diet and monitoring; a growth scan is not the first step.
- C. A fasting value of 5.5 mmol/L meets the ADIPS threshold (5.3 or more). One value is enough to diagnose GDM. First-line care is dietitian input and self-monitoring.
- D. One abnormal value is enough for the diagnosis, so reassurance is wrong.
- E. HbA1c is not used to confirm GDM at this gestation and is less sensitive than the OGTT.
Any single OGTT value at or above the ADIPS cut-off diagnoses GDM; start with diet and glucose monitoring.
Based on: ADIPS 2025 consensus on gestational diabetes
Example 2
A 32-year-old woman at 30 weeks' gestation calls her GP because her 4-year-old son developed chickenpox yesterday. She spent the morning with him. She cannot remember having had chickenpox and has no record of varicella vaccination. She is well with no rash. Her booking bloods did not include varicella serology.
What is the most appropriate next step?
-
Antivirals are used if chickenpox develops, or as an alternative in some settings, but the first step is to establish immunity.
-
Waiting for a rash loses the window for post-exposure prophylaxis.
-
Varicella vaccine is live and contraindicated in pregnancy.
-
Many adults without a clear history are immune, so test first. If non-immune, zoster immunoglobulin given early reduces the risk of severe maternal varicella.
-
Fetal ultrasound is relevant after maternal infection, not as the immediate response to exposure.
Show answer and reasoning
Answer: D. Test VZV IgG today; give immunoglobulin if negative
- A. Antivirals are used if chickenpox develops, or as an alternative in some settings, but the first step is to establish immunity.
- B. Waiting for a rash loses the window for post-exposure prophylaxis.
- C. Varicella vaccine is live and contraindicated in pregnancy.
- D. Many adults without a clear history are immune, so test first. If non-immune, zoster immunoglobulin given early reduces the risk of severe maternal varicella.
- E. Fetal ultrasound is relevant after maternal infection, not as the immediate response to exposure.
Varicella exposure in pregnancy with unknown immunity: urgent serology, then zoster immunoglobulin if non-immune.
Based on: Australian Immunisation Handbook: varicella
Example 3
A 24-year-old woman, blood group O RhD negative with a negative antibody screen at booking, presents at 22 weeks' gestation after a fall from a step onto her abdomen. She has no pain or bleeding. Fetal heart rate is 145 beats per minute. Her observations are normal and the uterus is soft and non-tender.
What is the most appropriate next step?
-
Anti-D is given after a sensitising event regardless; the Kleihauer test decides whether more is needed, not whether to give any.
-
Abdominal trauma after 20 weeks is a sensitising event. Give anti-D within 72 hours and send a Kleihauer test to size the bleed.
-
Fetomaternal haemorrhage can occur without symptoms, so reassurance alone is unsafe.
-
Waiting until 28 weeks would miss the 72-hour window for prophylaxis.
-
Monitoring is appropriate after significant trauma, but a stable woman with a minor fall still needs anti-D first.
Show answer and reasoning
Answer: B. Give anti-D and send a Kleihauer test today
- A. Anti-D is given after a sensitising event regardless; the Kleihauer test decides whether more is needed, not whether to give any.
- B. Abdominal trauma after 20 weeks is a sensitising event. Give anti-D within 72 hours and send a Kleihauer test to size the bleed.
- C. Fetomaternal haemorrhage can occur without symptoms, so reassurance alone is unsafe.
- D. Waiting until 28 weeks would miss the 72-hour window for prophylaxis.
- E. Monitoring is appropriate after significant trauma, but a stable woman with a minor fall still needs anti-D first.
After 20 weeks, a sensitising event in an RhD-negative woman means anti-D plus a Kleihauer test.
Based on: National guideline for prophylactic use of Rh D immunoglobulin in pregnancy care
Quick recall
Tap a card to turn it over. If you can answer all eight without looking, move on to timed questions.
Where candidates lose marks
- Old GDM thresholds
Many resources quote fasting 5.1 mmol/L. ADIPS raised it to 5.3 in 2025. Read the numbers in the stem and the guideline the question is based on.
- Giving live vaccines in pregnancy
MMR and varicella vaccines are live and wait until after birth. Inactivated vaccines are fine.
- Anti-D for an alloimmunised woman
If anti-D antibodies are already present, prophylaxis does nothing. Refer to fetal medicine instead.
- Stopping all medication
Stopping levothyroxine, insulin or an effective antiepileptic harms mother and baby. Adjust, do not stop.
- Reassuring reduced fetal movements
Reduced movements need same-day CTG and assessment, especially in the third trimester.
How to study antenatal care
Day 1: Learn the booking test list and the routine schedule table on this page; write it from memory twice.
Day 2: Gestational diabetes and overt diabetes in pregnancy using the ADIPS 2025 consensus; practise reading OGTT results.
Day 3: Vaccines and infections from the Australian Immunisation Handbook pregnancy chapter; make an exposure-response list.
Day 4: Anti-D, sensitising events and alloimmunisation; then thyroid, epilepsy, VTE and anaemia prescribing.
Day 5: Hyperemesis, cholestasis, twins and growth restriction; do 30 mixed antenatal questions under time.
Day 6: Review every wrong answer, note the deciding detail you missed, and redo the flashcards.
Sources and further reading
Check the current edition of each guideline before your exam. This page is study material, not clinical advice.
- Australian Government: Pregnancy Care Guidelines
- Australian Diabetes in Pregnancy Society (ADIPS)
- Australian Immunisation Handbook: Pregnancy
- National Blood Authority / Lifeblood: Rh D immunoglobulin guideline
- Australian Government: Syphilis information for health professionals
- RANZCOG clinical guidance statements
- Therapeutic Guidelines (eTG)